IRIS
GAMBA, GABRIELLA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.470
AS - Asia 2.626
EU - Europa 2.091
SA - Sud America 313
AF - Africa 83
OC - Oceania 6
Continente sconosciuto - Info sul continente non disponibili 2
Totale 8.591
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.402
CN - Cina 1.434
SG - Singapore 562
IE - Irlanda 445
UA - Ucraina 322
FI - Finlandia 259
HK - Hong Kong 231
BR - Brasile 219
DE - Germania 215
RU - Federazione Russa 212
VN - Vietnam 167
IT - Italia 144
GB - Regno Unito 132
SE - Svezia 122
FR - Francia 116
IN - India 50
ZA - Sudafrica 42
BD - Bangladesh 41
CA - Canada 40
PL - Polonia 35
AR - Argentina 34
IQ - Iraq 29
MX - Messico 20
NL - Olanda 20
BE - Belgio 19
JP - Giappone 16
CO - Colombia 15
EC - Ecuador 15
IR - Iran 15
ID - Indonesia 12
PK - Pakistan 12
ES - Italia 10
MU - Mauritius 10
VE - Venezuela 10
MA - Marocco 7
KE - Kenya 6
SA - Arabia Saudita 6
TR - Turchia 6
AU - Australia 5
CL - Cile 5
CZ - Repubblica Ceca 5
EG - Egitto 5
LT - Lituania 5
PE - Perù 5
PH - Filippine 5
PY - Paraguay 5
AT - Austria 4
BH - Bahrain 4
CH - Svizzera 4
OM - Oman 4
UZ - Uzbekistan 4
DK - Danimarca 3
DZ - Algeria 3
ET - Etiopia 3
GR - Grecia 3
JO - Giordania 3
LB - Libano 3
RO - Romania 3
UY - Uruguay 3
AE - Emirati Arabi Uniti 2
AL - Albania 2
AM - Armenia 2
AZ - Azerbaigian 2
BG - Bulgaria 2
BO - Bolivia 2
EU - Europa 2
GE - Georgia 2
HN - Honduras 2
IL - Israele 2
KG - Kirghizistan 2
KZ - Kazakistan 2
MY - Malesia 2
NI - Nicaragua 2
PA - Panama 2
PT - Portogallo 2
TH - Thailandia 2
BN - Brunei Darussalam 1
CG - Congo 1
CI - Costa d'Avorio 1
CR - Costa Rica 1
DJ - Gibuti 1
DM - Dominica 1
HR - Croazia 1
IS - Islanda 1
LV - Lettonia 1
MD - Moldavia 1
MG - Madagascar 1
NG - Nigeria 1
NZ - Nuova Zelanda 1
PS - Palestinian Territory 1
QA - Qatar 1
RS - Serbia 1
SI - Slovenia 1
SM - San Marino 1
SN - Senegal 1
SY - Repubblica araba siriana 1
TZ - Tanzania 1
Totale 8.591
Salva come PNG Salva come JPEG
Città #
San Jose 529
Dublin 442
Chandler 431
Jacksonville 405
Nanjing 322
Singapore 306
Ashburn 281
Beijing 234
Hong Kong 226
Dallas 174
Boardman 148
Nanchang 117
Shenyang 92
Lawrence 89
Princeton 89
Changsha 88
Hebei 86
Wilmington 85
Lauterbourg 79
Los Angeles 79
Jiaxing 75
Helsinki 72
Medford 61
Ho Chi Minh City 60
Ann Arbor 59
Tianjin 58
Hangzhou 47
Council Bluffs 44
Moscow 39
Hanoi 36
Buffalo 35
Woodbridge 34
Johannesburg 33
New York 33
Munich 28
Milan 24
Shanghai 23
São Paulo 23
Des Moines 22
Orem 22
Brussels 19
Warsaw 19
Redondo Beach 17
Santa Clara 17
Verona 17
Seattle 16
Turku 16
Frankfurt am Main 15
Houston 15
Kunming 15
Brooklyn 14
Chicago 14
Jinan 14
Radomsko 14
San Francisco 14
Tokyo 14
Baghdad 13
Manchester 13
Toronto 13
Chennai 12
Poplar 12
Amsterdam 11
Denver 11
London 11
Mexico City 11
Montreal 11
Norwalk 11
Taizhou 11
Ningbo 10
Atlanta 9
Boston 9
Dhaka 9
Fairfield 9
Guangzhou 9
Leawood 9
Stockholm 9
Zhengzhou 9
Mumbai 8
Rio de Janeiro 8
Dearborn 7
Fuzhou 7
Haiphong 7
Phoenix 7
Auburn Hills 6
Da Nang 6
Guayaquil 6
Hải Dương 6
Quito 6
Rome 6
The Dalles 6
Biên Hòa 5
Curitiba 5
Falkenstein 5
Falls Church 5
Jeddah 5
New Delhi 5
Nuremberg 5
Washington 5
Zanjan 5
Bogotá 4
Totale 5.737
Salva come PNG Salva come JPEG
Nome #
Coagulation-factor deficiencies and abnormal bleeding in Noonan’s syndrome 159
Activation of the haemostatic process in patients with unruptured aortic aneurysm before and after surgical repair 148
Caratteristiche dell'emartro ed evoluzione in artropatia nelle coagulopatie congenite: osservazione su 145 casi afferenti al centro emofilia di Pavia 145
Screening dei difetti dell'emostasi con Platelet Function Analyzer (PFA-100) in donne con meno-metrorragia 143
Acquired von Willebrand syndrome and monoclonal gammopathy: clinical characterization and recovery to infusion of VWF-containing concentrates 134
Abnormalities in thrombin-antithrombin pathway in primary systemic amyloidosis. 131
Perceived challenges and attitudes to regimen and product selection from Italian haemophilia treaters: the 2013 AICE survey. 130
An unconventional case of scurvy. 129
Atherosclerosis, vascular damage, thrombotic risk factors and congenital bleeding disorders 128
Screening for congenital bleeding disorders with platelet function analyzer (PFA-100) in women with menorrhagia 125
L'artropatia e l'emartro ricorrente nelle coagulopatie congenite: l'influenza del trattamento. 121
Acquired von Willebrand syndrome in inflammatory bowel disease 121
Activation of the haemostatic process in patients with unruptured aortic aneurysm before and in the first week after surgical repair. 121
Clotting alterations in primary systemic amyloidosis. 119
Intracranial haemorrhage in the Italian population of haemophilia patients with and without inhibitors. 116
Factor V Leiden mutation and risk of thrombotic complications in children treated for lynphoprolipherative diseases 115
Effect of low molecular weight heparin on some markers of platelet and thrombin activation in patients with inflammatory bowel diseasesnresponsive to the standard therapy 115
Cardiovascular disease, hyperhomocysteinemia and atherothrombotic risk factors in psoriatic patients 114
Bleeding disorders in children with reccurent tonsillitis and prolonged aPTT 114
Deferment of objective assessment of deep vein thrombosis and pulmonary embolism without increased risk of thrombosis: a practical approach based on the pretest clinical model, D-dimer testing, and the use of low-molecular-weight heparins. 114
Long-term evaluation of synovectomy and synoviorthesis on the evolution of joint damage: what's happened after 30 years of follow up? 114
La valutazione della qualità della vita e della artropatia nel paziente emofilico adulto. 113
Platelet-independent defect in hemostasis associated with sirolimus use 111
Mitral valve prolapse and prothrombotic risk factors in children and adolescents with migraine with aura and other idiopathic headaches 110
Haemostatic variables, serum lipid abnormalities and vascular complications in diabetes mellitus: a 5 year follow-up study. 110
Renal diseases in haemophilic patients: pathogenesis and clinical management. 109
Effetti sistemici della terapia trombolitica.[Systemic effects of thrombolytic therapy]. 108
Castleman's disease with coagulation defect. A case report. 108
Efficacy and safety of high doses of FEIBA for major surgery in a patient with haemophilia A and high titre inhibitor 107
Consumption of clotting factors in severe haemophilia patients undergoing prophylaxis and on-demand treatment in Italy. 105
Therapeutic management and costs of severe haemophilia A patients with inhibitors in Italy. 105
Valutazione dell'artropatia in soggetti affetti da emofilia. 105
Defective anticoagulation system in patients with previous myocardial infarction and residual angina 102
The behaviour of physiologic and acquired anticoagulants in patients with hyperhomocysteinemia and thrombotic complications 101
Demographic and clinical data in acquired hemophilia A: results from the European Acquired Haemophilia Registry (EACH2). 101
Patterns of bleeding,comorbidities, and clinical courses in acquired hemophilia A (AHA) and in acquired von Willebrand disease (AVWD): Experience from a single hemophiliaentre in Pavia 100
High prevalence of fibrin formation defects in women with menorrhagia and congenital bleeding disorders 99
Principles of treatment and update of recommendations for the management of haemophilia and congenital bleeding disorders in Italy. 98
In vitro and in vivo effects of desmopressin on platelet function 98
L'artropatia e l'emartro nelle coagulopatie congenite: l'influenza del trattamento 97
Liver damage and homocysteine plasma levels in haemophilia 95
Performance in sports of children and adolescents with hereditary bleeding disorders 95
Vascular damage, prothrombotic risk factor and trombosis in patients with inherited bleeding disorders 95
Efficacy and safety of factor VIII inhibitor by-passing activity (FEIBA) in high thrombotic risk patients with acquired haemophilia (AH) Efficacy and safety of factor VIII inhibitor by-passing activity (FEIBA) in high thrombotic risk patients with acquired haemophilia (AH) 95
Clotting alterations in primary systemic amyloidosis 94
Activated prothrombin complex concentrate (FEIBA®) for the treatment and prevention of bleeding in patients with acquired haemophilia: A sequential study 94
Hyperhomocysteinemia and FV ARG 506 GLN in 81 consecutive patients with thrombosis. 93
Malattia di von Willebrand acquisita in 2 pazienti con malattia infiammatoria cronica intestinale 93
Homocysteine, vitamin b12 and folic acid levels in psoriasi patients and correlation with disease severity. 93
PLASMA PROTEIN-Z LEVELS AND HEMOSTASIS IN PATIENTS ON DICUMAROL TREATMENT AND IN PATIENTS WITH BLEEDING TENDENCY OF UNKNOWN ORIGIN 92
Homocysteine plasma levels and vascular damage in congenital clotting factor deficiencies 92
Prevalenza di trombosi arteriose e venose in presenza delle mutazioni G20210A del gene della protrombina e R506Q del gene del FV (Leiden) 90
Pregnancy-associated acquired haemophilia A: results from the European Acquired Haemophilia (EACH2) registry. 90
Bleeding tendency of unknown origin and protein Z levels. 90
Thrombotic markers and mitral valve prolapse in migraine with and without aura at childhood onset 89
Immunosuppression for acquired hemophilia A: results from the European Acquired Haemophilia Registry (EACH2). 89
Mitral valve prolapse and abnormalities of haemostasis in children and adolescents with migraine with aura and other idiopathic headaches: a pilot study. 88
THROMBOPHILIC SCREENING IN TURNER SYNDROME. 87
Treatment of bleeding episodes in acquired haemophilia with activated prothrombin complex concentrate: what is the optimal therapy? 87
Platelet function after in vivo and in vitro treatment with thrombolytic agents 87
Desmopressin and platelets: In vitro and in vivo studies 86
Efficacy and safety during formulation switch of a pasteurized VWF/FVIII concentrate: results from an Italian prospective observational study in patients with von Willebrand disease. 86
Influenza del polimorfismo C677T del gene della MTHFR sui livelli di omocisteina plasmatici e sul rischio trombotico 85
Impaired expression of dipeptidylaminopeptidase IV (DAPN)/CD26 in lymphocytes of hemophiliacs 85
Von Willebrand factor/factor VIII behaviour and haemorrhagic manifestations in patients with neurofibromatosis type I 84
Plasma exchange and immunosuppressive therapy in a case of mild haemophilia A with inhibitors and a life-threatening lower limb haemorrhage. 83
Imbalance of oxidant and antioxidant mechanism in ischaemic heart diseases 79
Intraoperative intravenous administration of rFVIIa and hematoma volume after early surgery for spontaneous intracerebral hemorrhage: a randomized prospective phase II study. 79
Normalization of homocysteine plasma levels improves the physiological anticoagulation in patients with thromboembolic diseases 79
Prolonged aPTT occasionally detected in children before adenotonsillectomy and bleeding disorders 79
Haemarthroses and arthropathy in mild/moderate haemophilia: data collected from a single Haemophilia Centre, Pavia, Italy 78
Treatment and progression of liver damage in HCV+ haemophiliacs: over 15 years follow up 77
Homocysteine and liver steatosis in HCV infected haemophiliacs 75
Risk factors of thrombosis in poorly controlled inflammatory bowel diseases: benefecial effect of LMW heparin as adjuvant therapy 73
Expression of dipeptidylaminopeptidase IV-CD26 in circulating lymphocytes of homophilic subjects 73
Intraoperative intravenous administration of rFVIIa and hematoma volume after early surgery for spontaneous intracerebral hemorrhage: a randomized prospective phase II study 73
HEPARIN INFUSION FACILITATES PLATELETS ACTIVABILITY IN PATIENTS WITH ACUTE MYOCARDIAL-INFARCTION WHO HAVE UNDERGONE THROMBOLYTIC THERAPY 72
Long-term follow up in Acquired Hemophilia A: clinical courses and outcomes observed in a single Hemophilia Centre 71
Preoperative bleeding risk assessment with ISTH-BAT and laboratory tests in patients undergoing elective surgery: A prospective cohort study 70
Modalità di diagnosi e caratteristiche cliniche della M di von Willebrand acquisita 69
Two years prophylaxis with FEIBA and inhibitors levels in a high responder haemophilic patient 68
Platelet aggregation in platelet rich plasma and whole blood in 18 patients affected by agnogenic myeloid metaplasia 67
Mitral valve prolapse and abnormalities of haemostasis in children and adolescents with migraine with aura and other idiopathic headaches: a pilot study. 67
Menometrorrhagia in adolescents: is it the first expression of congenital defects of hemostasis 66
Ruolo patogenetico delle alterazioni emocoagulative nell'insorgenza di s poliabortiva e di patologie ostetriche 66
Thromboembolic disease and thrombotic risk factors: The effect of treating Hìhyperhomocysteinemia on physiological anticoagulation 66
Interobserver reliability of ultrasound assessment of haemophilic arthropathy: Radiologist vs. non-radiologist 64
Haemostasis and low molecular weight heparin (LMWH) therapy in chronic inflammatory bowel diseases (IBD) not responsive to conventional therapy. 63
Study of three patients with monoclonal gammopathies and 'lupus-like' anticoagulants 57
Management of bleeding in acquired hemophilia A: results from the European Acquired Haemophilia (EACH2) Registry. 52
Totale 8.663
Salva come PNG Salva come JPEG
Categoria #
all - tutte 34.379
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 34.379
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202118 0 0 0 0 0 0 0 0 0 0 0 18
2021/2022418 12 0 13 9 3 10 13 20 33 13 50 242
2022/20231.270 146 85 2 111 148 137 0 62 508 17 35 19
2023/2024363 67 51 18 31 48 81 0 34 5 10 14 4
2024/20251.070 15 97 25 33 21 47 21 78 269 29 139 296
2025/20262.956 233 202 295 347 322 125 706 123 224 191 157 31
Totale 8.663